Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers

Since the end of 2019, global healthcare systems have been dealing with the COVID-19 pandemic. In oncology, the biggest questions concern interaction of COVID-19 with pre-existing cancer disease and with systemic anticancer treatments. With regards to immunotherapy, there is uncertainty about its ef...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Saponara, Maristella, Pala, Laura, Conforti, Fabio, Rubatto, Marco, De Risi, Ivana, Spagnolo, Francesco, Guida, Michele, Bossi, Paolo, Quaglino, Pietro, Queirolo, Paola
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Case Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7684275/
https://ncbi.nlm.nih.gov/pubmed/33273966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920977002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars